Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Ipsen
Scientific Title
A Randomized, Open Label Phase 3 Study of Irinotecan Liposome Injection (ONIVYDE®) Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Progressed on or After Platinum-based First-Line Therapy